Recro Pharma

REPH

Sector
Healthcare

Industry
Biotechnology

Website
recropharma.com




Buy / Sell (dollars)

1 Month

0% 0% Complete (success)
0% 0% Complete (danger)
$0.00
avg. $0.00
$0.00
avg. $0.00

Buy/Sell Ratio

0

Transactions

0

Filers

0

3 Month

98.1% 98.1% Complete (success)
1.9% 1.9% Complete (danger)
$357,500.00
avg. $119,166.67
$6,866.45
avg. $2,288.82

Buy/Sell Ratio

52.065

Transactions

3

Filers

2

12 Month

30.8% 30.8% Complete (success)
69.2% 69.2% Complete (danger)
$640,395.00
avg. $53,366.25
$1.436M
avg. $119,658.19

Buy/Sell Ratio

0.446

Transactions

33

Filers

11

24 Month

5.9% 5.9% Complete (success)
94.1% 94.1% Complete (danger)
$468,727.00
avg. $19,530.29
$7.499M
avg. $312,473.35

Buy/Sell Ratio

0.063

Transactions

105

Filers

19

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.



Filers